Decibel Cannabis Company Inc. (DB.V)
CAD 0.07
(0.0%)
CAD 0.07
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 32.34 Million CAD | -16.71% |
| 2022 | 38.83 Million CAD | 39.98% |
| 2021 | 27.74 Million CAD | -32.32% |
| 2020 | 40.99 Million CAD | 7.54% |
| 2019 | 38.12 Million CAD | 915.85% |
| 2018 | 3.75 Million CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | -100.0% |
| 2006 | 398.12 Thousand CAD | -61.86% |
| 2005 | 1.04 Million CAD | 0.0% |
| 2004 | - CAD | 0.0% |
| 2003 | - CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| 2000 | - CAD | 0.0% |
| 1999 | - CAD | 0.0% |
| 1998 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 30.91 Million CAD | -2.26% |
| 2024 Q1 | 31.63 Million CAD | -2.21% |
| 2023 Q3 | 37.57 Million CAD | -2.41% |
| 2023 FY | 32.34 Million CAD | -16.71% |
| 2023 Q2 | 38.5 Million CAD | -2.2% |
| 2023 Q1 | 39.36 Million CAD | 1.36% |
| 2023 Q4 | 32.34 Million CAD | -13.91% |
| 2022 Q4 | 38.83 Million CAD | -1.52% |
| 2022 Q1 | 29.15 Million CAD | 5.06% |
| 2022 Q2 | 39.53 Million CAD | 35.62% |
| 2022 FY | 38.83 Million CAD | 39.98% |
| 2022 Q3 | 39.43 Million CAD | -0.25% |
| 2021 Q2 | 29.36 Million CAD | -28.19% |
| 2021 Q1 | 40.88 Million CAD | -0.27% |
| 2021 FY | 27.74 Million CAD | -32.32% |
| 2021 Q4 | 27.74 Million CAD | -2.95% |
| 2021 Q3 | 28.58 Million CAD | -2.63% |
| 2020 Q1 | 37.71 Million CAD | -1.08% |
| 2020 Q4 | 40.99 Million CAD | 31.49% |
| 2020 Q3 | 31.18 Million CAD | -17.71% |
| 2020 FY | 40.99 Million CAD | 7.54% |
| 2020 Q2 | 37.88 Million CAD | 0.47% |
| 2019 Q2 | 14 Million CAD | 239.0% |
| 2019 Q1 | 4.13 Million CAD | 0.0% |
| 2019 FY | 38.12 Million CAD | 915.85% |
| 2019 Q4 | 38.12 Million CAD | 169.28% |
| 2019 Q3 | 14.15 Million CAD | 1.1% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 FY | 3.75 Million CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 FY | - CAD | -100.0% |
| 2006 Q2 | 398.12 Thousand CAD | 96.87% |
| 2006 Q3 | 259.03 Thousand CAD | -34.94% |
| 2006 Q1 | 202.22 Thousand CAD | -10.56% |
| 2006 Q4 | - CAD | -100.0% |
| 2006 FY | 398.12 Thousand CAD | -61.86% |
| 2005 Q3 | 1 Million CAD | -3.73% |
| 2005 Q2 | 1.04 Million CAD | -5.86% |
| 2005 FY | 1.04 Million CAD | 0.0% |
| 2005 Q4 | 226.1 Thousand CAD | -77.5% |
| 2005 Q1 | 1.1 Million CAD | 3.38% |
| 2004 Q1 | - CAD | -100.0% |
| 2004 Q2 | - CAD | 0.0% |
| 2004 Q4 | 1.07 Million CAD | 4216.26% |
| 2004 FY | - CAD | 0.0% |
| 2004 Q3 | 24.85 Thousand CAD | 0.0% |
| 2003 FY | - CAD | 0.0% |
| 2003 Q4 | 120 Thousand CAD | 0.0% |
| 2003 Q3 | 120 Thousand CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2001 Q1 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| 2001 Q4 | - CAD | 0.0% |
| 2001 Q3 | - CAD | 0.0% |
| 2001 Q2 | - CAD | 0.0% |
| 2000 Q2 | - CAD | 0.0% |
| 2000 FY | - CAD | 0.0% |
| 2000 Q3 | - CAD | 0.0% |
| 1999 Q3 | 114.7 Thousand CAD | 0.0% |
| 1999 FY | - CAD | 0.0% |
| 1998 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 583.58 Thousand CAD | -5442.971% |
| CanadaBis Capital Inc. | 5.91 Million CAD | -446.755% |
| Delivra Health Brands Inc. | 1.78 Million CAD | -1712.213% |
| Entourage Health Corp. | 5.79 Million CAD | -458.393% |
| Lifeist Wellness Inc. | 868.65 Thousand CAD | -3623.909% |
| Cannara Biotech Inc. | 39.73 Million CAD | 18.598% |
| Medicure Inc. | 229 Thousand CAD | -14025.764% |
| PharmaCielo Ltd. | 2.55 Million CAD | -1166.853% |
| Rubicon Organics Inc. | - CAD | -Infinity% |
| BioSyent Inc. | 1.03 Million CAD | -3017.185% |
| Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -80770.0% |